Infantile scabies, Ann Dermatol Venereol, vol.135, p.87681, 2008. ,
Scabies: What???s New?, Curr. Probl. Dermatol, vol.22, p.10511, 1995. ,
DOI : 10.1159/000424240
La gale est-elle en augmentation en France? État des lieux à partir de diverses enquêtes régionales et nationales 2008-2010. Saint-Maurice: Institut de veille sanitaire, Disponible sur, 2011. ,
Scabies: a common infection in children, Arch Pediatr, vol.19, p.125960, 2012. ,
Scabies in the developing world???-its prevalence, complications, and management, Clinical Microbiology and Infection, vol.18, issue.4, p.31323, 2012. ,
DOI : 10.1111/j.1469-0691.2012.03798.x
Skin infections and infestations in Aboriginal communities in northern Australia, Australasian Journal of Dermatology, vol.22, issue.3, p.13943, 2000. ,
DOI : 10.1016/S0140-6736(96)90797-7
Analytical Study of Pustular Eruptions in Neonates, Pediatric Dermatology, vol.16, issue.3, p.2105, 2002. ,
DOI : 10.1046/j.1365-2133.1997.d01-1235.x
Palmoplantar pustules in an infant. Acropustulosis of infancy, Arch Dermatol, vol.132, pp.13656-13689, 1996. ,
Dermoscopy for the in vivo Detection of <i>Sarcoptes scabiei</i>, Dermatology, vol.208, issue.3, p.2413, 2004. ,
DOI : 10.1159/000077310
Accuracy of standard dermoscopy for diagnosing??scabies, Journal of the American Academy of Dermatology, vol.56, issue.1, p.5362, 2007. ,
DOI : 10.1016/j.jaad.2006.07.025
Epiluminescence microscopy. A new approach to in vivo detection of Sarcoptes scabiei, Archives of Dermatology, vol.133, issue.6, p.7513, 1997. ,
DOI : 10.1001/archderm.133.6.751
The immunology of scabies, Semin Dermatol, vol.12, p.1521, 1993. ,
Life cycle of scabies mite (Sarcoptes scabiei var. hominis) studied by scanning electron microscopy (authors transl), Ann Dermatol Venereol, vol.108, p.35561, 1981. ,
Permethrin and Ivermectin for Scabies, New England Journal of Medicine, vol.362, issue.8, p.71725, 2010. ,
DOI : 10.1056/NEJMct0910329
Modulation of cytokine expression in human keratinocytes and fibroblasts by extracts of scabies mites, Am J Trop Med Hyg, vol.69, p.6526, 2003. ,
Scabies and pediculosis, The Lancet, vol.355, issue.9206, p.81926, 2000. ,
DOI : 10.1016/S0140-6736(99)09458-1
Epidemic scabies in four Caribbean islands, 1981???1988, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.84, issue.2, p.298300, 1990. ,
DOI : 10.1016/0035-9203(90)90296-Q
An epidemic of acute post-streptococcal glomerulonephritis among Aboriginal children, Journal of Paediatrics and Child Health, vol.159, issue.3, p.2458, 1995. ,
DOI : 10.1016/S0140-6736(73)90324-3
Outcome of an interventional program for scabies in an Indigenous community, Med J Aust, vol.175, p.36770, 2001. ,
EPIDEMIC SCABIES AND ACUTE GLOMERULONEPHRITIS IN TRINIDAD, The Lancet, vol.299, issue.7744, p.24951, 1972. ,
DOI : 10.1016/S0140-6736(72)90634-4
Wastage of family income on skin disease in Mexico, BMJ, vol.309, issue.6958, p.848, 1994. ,
DOI : 10.1136/bmj.309.6958.848
Recommandations relatives à la conduite à tenir devant un ou plusieurs cas de gale, 2012. ,
Epidémie de gale communautaire Guide dinvestigation et daide à la gestion. Saint-Maurice (Fra): Institut de veille sanitaire, 2008. ,
Safety of permethrin vs lindane for the treatment of scabies, Arch Dermatol, vol.132, p.95962, 1996. ,
Treatment of scabies with permethrin versus lindane and benzyl benzoate, Acta Derm. Venereol, vol.69, p.34851, 1989. ,
Scabies: transcutaneous poisoning during treatment, Pediatrics, vol.59, p.643, 1977. ,
Ivermectin as an Antiparasitic Agent for Use in Humans, Annual Review of Microbiology, vol.45, issue.1, p.44574, 1991. ,
DOI : 10.1146/annurev.mi.45.100191.002305
Efficacy and tolerance of ivermectin in human onchocerciasis, Lancet, vol.2, p.1713, 1982. ,
Effect of ivermectin on feeding by Haemonchus contortus in vivo, Veterinary Parasitology, vol.128, issue.3-4, p.3416, 2005. ,
DOI : 10.1016/j.vetpar.2004.12.008
Haemonchus contortus, Exp Parasitol, vol.77, p.8896, 1993. ,
DOI : 10.1016/bs.apar.2016.02.013
Modes of action of anthelmintic drugs, The Veterinary Journal, vol.154, issue.1, p.1134, 1997. ,
DOI : 10.1016/S1090-0233(05)80005-X
Ivermectin and Abamectin. Toxicology. Campbell WC editor, pp.89-112, 1989. ,
P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs., Journal of Clinical Investigation, vol.97, issue.11, p.251724, 1996. ,
DOI : 10.1172/JCI118699
Ivermectin: pharmacology and application in dermatology, International Journal of Dermatology, vol.123, issue.12, p.9818, 2005. ,
DOI : 10.1016/S0140-6736(94)91625-X
ABCB1 (P-glycoprotein) and blood-brain barrier: role in neurological diseases and their treatments, J Pharm Clin, vol.25, p.22535, 2006. ,
Capture, efflux et modulation du transport des médicaments au niveau cérébral, Journal de Pharmacie Clinique, vol.20, p.5263, 2001. ,
The blood-brain barrier: Morphology, molecules, and neurothelin, BioEssays, vol.19, issue.5, p.3416, 1993. ,
DOI : 10.1002/bies.950150508
Morphology and physiology of the blood-brain barrier, Ann Fr Anesth Reanim, vol.22, p.20214, 2003. ,
Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites., Proceedings of the National Academy of Sciences, vol.86, issue.2, p.6958, 1989. ,
DOI : 10.1073/pnas.86.2.695
Ivermectin excretion by isolated functionally intact brain endothelial capillaries, British Journal of Pharmacology, vol.13, issue.Suppl 1, p.7228, 2001. ,
DOI : 10.1038/sj.bjp.0703762
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572593
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.455, issue.1, p.15262, 1976. ,
DOI : 10.1016/0005-2736(76)90160-7
Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues., Proceedings of the National Academy of Sciences, vol.84, issue.21, p.77358, 1987. ,
DOI : 10.1073/pnas.84.21.7735
The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor, Anti-Cancer Drugs, vol.7, issue.7, p.74551, 1996. ,
DOI : 10.1097/00001813-199609000-00005
P-glycoprotein and bioavaibility-implication of polymorphism, Clin Chem Lab Med, vol.38, p.87781, 2000. ,
Review of Ivermectin in Scabies, Journal of Cutaneous Medicine and Surgery: Incorporating Medical and Surgical Dermatology, vol.5, issue.6, p.496504, 2001. ,
DOI : 10.1007/s10227-001-0015-z
Ivermectin: A Few Caveats Are Warranted Before Initiating Therapy for Scabies, Archives of Dermatology, vol.135, issue.12, p.154950, 1999. ,
DOI : 10.1001/archderm.135.12.1549
Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects, Journal of Clinical Pharmacology, vol.42, issue.10, p.112233, 2002. ,
DOI : 10.1177/009127002401382731
Safety of and compliance with community-based ivermectin therapy, The Lancet, vol.335, issue.8702, p.137780, 1990. ,
DOI : 10.1016/0140-6736(90)91253-7
Part Introduction, in Neonatal Formulary 6: Drug Use in Pregnancy and the First Year of Life, 2011. ,
Ivermectin a new therapeutic weapon in dermatology, Arch Dermatol, vol.135, p.7056, 1999. ,
The Global Programme to Eliminate Lymphatic Filariasis: Health Impact after 8 Years, PLoS Neglected Tropical Diseases, vol.367, issue.10, p.317, 2008. ,
DOI : 10.1371/journal.pntd.0000317.s001
The treatment of scabies with oral ivermectin, Gac Med Mex, vol.129, p.2015, 1993. ,
The Treatment of Scabies with Ivermectin, New England Journal of Medicine, vol.333, issue.1, p.2630, 1995. ,
DOI : 10.1056/NEJM199507063330105
A field study of the effects of ivermectin on ectoparasites of man, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.85, issue.4, p.5501, 1991. ,
DOI : 10.1016/0035-9203(91)90255-W
The use of ivermectin for scabies, Natl Med J India, vol.7, p.156, 1994. ,
Efficacy and tolerance of oral ivermectin in scabies, Journal of the European Academy of Dermatology and Venereology, vol.335, issue.3, p.24751, 1998. ,
DOI : 10.1046/j.1365-4362.1998.00330.x
Current treatments for scabies, Fundamental and Clinical Pharmacology, vol.9, issue.2, p.21725, 2003. ,
DOI : 10.1001/archderm.133.10.1314
Equivalent Therapeutic Efficacy and Safety of Ivermectin and Lindane in the Treatment of Human Scabies, Archives of Dermatology, vol.135, issue.6, p.6515, 1999. ,
DOI : 10.1001/archderm.135.6.651
Comparison of ivermectin and benzyl benzoate for treatment of scabies, Trop Med Parasitol, vol.44, p.3312, 1993. ,
Oral Ivermectin in Scabies Patients: A Comparison with 1% Topical Lindane Lotion, The Journal of Dermatology, vol.7, issue.9, p.4814, 2001. ,
DOI : 10.1111/j.1346-8138.2001.tb00015.x
Ivermectin for Sarcoptes scabiei hyperinfestation, International Journal of Infectious Diseases, vol.2, issue.3, p.1524, 1998. ,
DOI : 10.1016/S1201-9712(98)90118-7
URL : http://doi.org/10.1016/s1201-9712(98)90118-7
Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog1, Mol Biochem Parasitol, vol.91, p.32735, 1998. ,
First Documentation of In Vivo and In Vitro Ivermectin Resistance in Sarcoptes scabiei, Clinical Infectious Diseases, vol.39, issue.1, p.812, 2004. ,
DOI : 10.1086/421776
Ivermectin: uses and impact 20 years on, Current Opinion in Infectious Diseases, vol.19, issue.6, p.58893, 2006. ,
DOI : 10.1097/QCO.0b013e328010774c
Ivermectin is better than benzyl benzoate for childhood scabies in developing countries, Journal of Paediatrics and Child Health, vol.135, issue.4, p.4014, 2002. ,
DOI : 10.1046/j.1525-1470.1999.016001069.x
Treatment of 18 children with scabies or cutaneous larva migrans using ivermectin, Clinical and Experimental Dermatology, vol.349, issue.4, p.2647, 2002. ,
DOI : 10.1046/j.1365-4362.1999.00662.x
Crusted scabies in two immunocompromised children: Successful treatment with oral ivermectin, Australasian Journal of Dermatology, vol.40, issue.1, p.3740, 1999. ,
DOI : 10.1001/archderm.132.8.901
Ivermectin-responsive crusted scabies in four patients, Pediatr Dermatol, vol.16, p.6970, 1999. ,
Crusted Scabies in an Immunocompetent Child: Treatment with Ivermectin, Pediatric Dermatology, vol.132, issue.2, p.1448, 2000. ,
DOI : 10.1097/00006454-199810000-00017
Oral Treatment of Crusted Scabies with Ivermectin: Report of Two Cases, Pediatric Dermatology, vol.40, issue.5, p.4104, 2000. ,
DOI : 10.1056/NEJM199503023320917
Crusted (Norwegian) scabies induced by use of topical corticosteroids and treated successfully with ivermectin, The Journal of Pediatrics, vol.135, issue.1, p.1224, 1999. ,
DOI : 10.1016/S0022-3476(99)70342-2
Ivermectin for Crusted Norwegian Scabies Induced by Use of Topical Steroids, Archives of Dermatology, vol.134, issue.2, p.1435, 1998. ,
DOI : 10.1001/archderm.134.2.143
Scabies therapy for the millenium, Pediatr Dermatol, vol.17, p.1546, 2000. ,
Control of scabies, skin sores and haematuria in children in the Salomon Islands: another role for ivermectin, Bull World Health Organ, vol.83, p.3442, 2005. ,
Pediculosis capitis tratamiento de la escabiasis con ivermectina, Act Ter Dermatol, vol.20, p.99103, 1997. ,
Oral Ivermectin versus Malathion Lotion for Difficult-to-Treat Head Lice, New England Journal of Medicine, vol.362, issue.10, p.896905, 2010. ,
DOI : 10.1056/NEJMoa0905471
Ivermectin use in scabies, Am Fam Physician, vol.68, p.108992, 2003. ,
Deaths associated with ivermectin treatment of scabies, The Lancet, vol.349, issue.9059, p.11445, 1997. ,
DOI : 10.1016/S0140-6736(05)63020-6
Ivermectin for scabies, The Lancet, vol.350, issue.9090, p.1551, 1997. ,
DOI : 10.1016/S0140-6736(05)63983-9
Ivermectin in Elderly Patients, Archives of Dermatology, vol.135, issue.3, p.3512, 1999. ,
DOI : 10.1001/archderm.135.3.351
Deaths associated with ivermectin for scabies, The Lancet, vol.350, issue.9072, pp.215-216, 1997. ,
DOI : 10.1016/S0140-6736(05)62377-X
Deaths associated with ivermectin for scabies, The Lancet, vol.350, issue.9072, p.2156, 1997. ,
DOI : 10.1016/S0140-6736(05)62378-1
Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene, Pharmacogenetics, vol.11, issue.8, p.72733, 2001. ,
DOI : 10.1097/00008571-200111000-00012
MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin, European Journal of Pharmacology, vol.460, issue.2-3, p.8591, 2003. ,
DOI : 10.1016/S0014-2999(02)02955-2
Brain penetration of ivermectin and selamectin in mdr1a,b P-glycoprotein-and bcrp-deficient knockout mice, J Vet Pharmacol Ther, vol.32, p.8796, 2009. ,
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs, Cell, vol.77, issue.4, p.491502, 1994. ,
DOI : 10.1016/0092-8674(94)90212-7
Multidrug resistance and the role of P-glycoprotein knockout mice, European Journal of Cancer, vol.31, issue.7-8, p.12958, 1995. ,
DOI : 10.1016/0959-8049(95)00130-B
P-Glycoprotein gene (MDR1) cDNA from human adrenal: Normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance, Biochemical and Biophysical Research Communications, vol.162, issue.1, p.22431, 1989. ,
DOI : 10.1016/0006-291X(89)91985-2
Potential impact of ABCB1 (p-glycoprotein) polymorphisms on avermectin toxicity in humans, Archives of Toxicology, vol.63, issue.7, p.55363, 2007. ,
DOI : 10.1007/s00204-007-0193-6
Digoxin pharmacokinetics and MDR1 genetic polymorphisms, European Journal of Clinical Pharmacology, vol.71, issue.12, p.80912, 2003. ,
DOI : 10.1067/mcp.2002.121152
Influence of functional haplotypes in the drug transporter gene ABCB1 on central nervous system drug distribution in humans, Clin Pharmacol Ther, vol.78, p.18290, 2005. ,
Current pharmacotherapy in the newborn, Research and Reports in Neonatology, vol.2, pp.85-94, 2012. ,
DOI : 10.2147/RRN.S28746
Barrier Mechanisms in the Developing Brain, Frontiers in Pharmacology, vol.3 ,
DOI : 10.3389/fphar.2012.00046
BARRIER MECHANISMS IN THE BRAIN, II. IMMATURE BRAIN, Clinical and Experimental Pharmacology and Physiology, vol.26, issue.2, p.8591, 1999. ,
DOI : 10.1007/s004290050042
THE DEVELOPMENT OF THE HUMAN BLOOD-BRAIN AND BLOOD-CSF BARRIERS, Neuropathology and Applied Neurobiology, vol.33, issue.4, p.33758, 1986. ,
DOI : 10.1002/cne.902040105
Barriers in the developing brain and Neurotoxicology, NeuroToxicology, vol.33, issue.3, pp.586-604, 2012. ,
DOI : 10.1016/j.neuro.2011.12.009
The multidrug-resistance P-glycoprotein (Pgp, MDR1 ) is an early marker of blood-brain barrier development in the microvessels of the developing human brain, Histochemistry and Cell Biology, vol.108, issue.2, p.17982, 1997. ,
DOI : 10.1007/s004180050159
P-glycoprotein in the placenta: Expression, localization, regulation and function, Reproductive Toxicology, vol.22, issue.3, p.40010, 2006. ,
DOI : 10.1016/j.reprotox.2006.01.007
Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice, Reproductive Toxicology, vol.12, issue.4, p.45763, 1998. ,
DOI : 10.1016/S0890-6238(98)00027-6
Absence of any adverse effect of inadvertent ivermectin treatment during pregnancy, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.87, issue.3, p.318, 1993. ,
DOI : 10.1016/0035-9203(93)90146-H
Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution, The Lancet, vol.336, issue.8729, p.14869 ,
DOI : 10.1016/0140-6736(90)93187-T
Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis, Tropical Medicine and International Health, vol.48, issue.12, p.1093101, 2003. ,
DOI : 10.1016/0140-6736(90)93187-T
Ivermectin and pregnancy in mass treatment in Mali, Bull Soc Pathol Exot, vol.85, p.24751, 1992. ,
La gale en France entre 1999??et 2010??: augmentation de l???incidence et implications en sant?? publique, Annales de Dermatologie et de V??n??r??ologie, vol.139, issue.6-7, pp.428-462, 2012. ,
DOI : 10.1016/j.annder.2012.01.023
The epidemiology of head lice and scabies in the UK, Epidemiology and Infection, vol.122, issue.3 ,
DOI : 10.1017/S0950268899002277
La gale du nourrisson, Annales de Dermatologie et de V??n??r??ologie, vol.135, issue.12, pp.876-81, 2008. ,
DOI : 10.1016/j.annder.2008.06.006
Scabies in the developing world???-its prevalence, complications, and management, Clinical Microbiology and Infection, vol.18, issue.4, pp.313-336, 2012. ,
DOI : 10.1111/j.1469-0691.2012.03798.x
Scabies: transcutaneous poisoning during treatment, Pediatrics, vol.59, p.643, 1977. ,
Treatment of 18 children with scabies or cutaneous larva migrans using ivermectin, Clin Exp Dermatol, vol.27, pp.264-271, 2002. ,
Oral Treatment of Crusted Scabies with Ivermectin: Report of Two Cases, Pediatric Dermatology, vol.40, issue.5, pp.410-414, 2000. ,
DOI : 10.1056/NEJM199503023320917
Crusted scabies in two immunocompromised children: Successful treatment with oral ivermectin, Australasian Journal of Dermatology, vol.40, issue.1, pp.37-40, 1999. ,
DOI : 10.1001/archderm.132.8.901
VERMECTIN-RESPONSIVE CRUSTED SCABIES IN FOUR PATIENTS, Pediatric Dermatology, vol.44, issue.1, pp.69-70, 1999. ,
DOI : 10.1016/0035-9203(91)90255-W
Crusted (Norwegian) scabies induced by use of topical corticosteroids and treated successfully with ivermectin, The Journal of Pediatrics, vol.135, issue.1, pp.122-126, 1999. ,
DOI : 10.1016/S0022-3476(99)70342-2
Ivermectin for Crusted Norwegian Scabies Induced by Use of Topical Steroids, Archives of Dermatology, vol.134, issue.2, pp.143-148, 1998. ,
DOI : 10.1001/archderm.134.2.143
Crusted Scabies in an Immunocompetent Child: Treatment with Ivermectin, Pediatric Dermatology, vol.132, issue.2, pp.144-152, 2000. ,
DOI : 10.1097/00006454-199810000-00017
Barrier mechanisms in the brain, II ,
Absence of any adverse effect of inadvertent ivermectin treatment during pregnancy, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.87, issue.3, p.318, 1993. ,
DOI : 10.1016/0035-9203(93)90146-H